,13 By activating proteasomal degradation of IKZF1 and IKZF3, coupled with immunomodulatory effects, inhibition of angiogenesis, and disruption of MM cells with bone marrow stroma, pomalidomide exhibits potent anti-MM activity.11 The gene discussed is IKZF1; the disease is Miyoshi myopathy.